article · The Lancet Oncology

CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trials

Mohammed S. Beshr
Mohamed Alsharedi
Ahmed Elkhanany
Antonios Valachis
Alzahraa Faris Alesawy
Ammar Fahaid
Rana H. Shembesh
Ahmed Abraheem
Galina Velikova
Mohamed E Ali
Matteo Lambertini
Laura Cortesi
Hatem A. Azim
Muhammed Elhadi

2026University of Tripoli

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Advanced Breast Cancer Therapies
HER2/EGFR in Cancer Research
Breast Cancer Treatment Studies

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/s1470-2045(26)00053-7

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.